Skip to main content
Skip to section navigation
Skip to footer
Home
About Us
Overview
Leadership
Board of Directors
Scientific Advisors (DMD)
Our Science
Deramiocel (Biologic Medicine)
Exosomes Technology
Publications
Strategic Partnerships
Pipeline
Pipeline
Duchenne Muscular Dystrophy Overview
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
In the News
IR Calendar
Presentations
Email Alerts
Company Info
Overview
Leadership
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Latest Proxy Statement and Annual Report
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity
Filing Type:
View All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
15-12B
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
REGDEX
S-1
S-1/A
S-3
S-3/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
Date
Form
Description
PDF
XBRL
Pages
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
02/14/20
4
Statement of changes in beneficial ownership of securities
2
12/27/19
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
12/19/19
4
Statement of changes in beneficial ownership of securities
1
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
18
Page
19
Page
20
Page
21
Page
22
Page
23
Page
24
Page
25
Page
26
Page
27
…
Page
86
Next Page
arrow_forward
Select a page:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
Page 10
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Page 18
Page 19
Page 20
Page 21
Page 22
Page 23
Page 24
Page 25
Page 26
Page 27
Page 28
Page 29
Page 30
Page 31
Page 32
Page 33
Page 34
Page 35
Page 36
Page 37
Page 38
Page 39
Page 40
Page 41
Page 42
Page 43
Page 44
Page 45
Page 46
Page 47
Page 48
Page 49
Page 50
Page 51
Page 52
Page 53
Page 54
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Page 63
Page 64
Page 65
Page 66
Page 67
Page 68
Page 69
Page 70
Page 71
Page 72
Page 73
Page 74
Page 75
Page 76
Page 77
Page 78
Page 79
Page 80
Page 81
Page 82
Page 83
Page 84
Page 85
Page 86
Email Alerts
Company Profile
Contacts
RSS News Feed